Etrolizumab as an induction and maintenance therapy for ulcerative colitis: A systematic review and meta‐analysis of randomized controlled trials

Abstract Background and Aim Etrolizumab is a gut‐targeted anti‐β7 integrin monoclonal antibody. However, the evidence of etrolizumab efficacy and safety in ulcerative colitis remains inconclusive. Therefore, we aim to evaluate the safety and efficacy of etrolizumab as an induction and maintenance th...

Full description

Bibliographic Details

Published in:	JGH Open
Main Authors:	Othman Saleh, Mohamed T. Abuelazm, Islam Mohamed, Alaa Ramadan, Mohammad Assaf, Ahmad Alzoubi, Majd M. AlBarakat, Basel Abdelazeem
Format:	Article
Language:	English
Published:	Wiley 2024-04-01
Subjects:	colon etrolizumab inflammatory bowel disease meta‐analysis review ulcerative colitis
Online Access:	https://doi.org/10.1002/jgh3.13056